Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Its All In The Name:...

    Its All In The Name: State drug regulators told to BAN marketing of new formulations in old brand names

    Farhat NasimWritten by Farhat Nasim Published On 2019-05-17T17:37:03+05:30  |  Updated On 17 Aug 2021 11:40 AM IST

    New Delhi: In a major setback to many pharma companies in the country, the ruling Government is reported to have directed state drug controllers to prevent pharma companies to sell new drugs under old brand names.


    This comes in response to the practice of pharma companies that have built a particular brand name and go ahead to use the brand name for a different API(active pharmaceutical ingredient)/ altered API.


    The Government has come up with the move after the expert panel is of the view that such drugs wherein the ingredients are changed or altered by the companies while retaining the same brand name is misleading. Besides, such practices may result in undesirable pharmacological effects as the consumer would take the formulation considering it as the earlier composition.


    A recent report in TOI states about the new policy move of the Government, adding that the Government order will also hit the sale of widely used household drugs. It is learnt that certain drugs are marketed with modified formulations which are marketed without changing the brand name.


    This is done in order to take the advantage associated with the brand. TOI reports that these include Corex as Corex DZ, Zifi AZ under the new brand name Zifi OZ, Panderm Plus as Panderm NM, Zeet syrup retains the brand name ZEET, Zedex plus as Zedex, Macbery syrup as MACBERY.


    Establishing brand name certainly helps a company relaunch its product but may create confusion regarding the ingredient inside a product, for example, Pfizer changed the cough syrup preparation and relaunched it while retaining the old brand name Corex after its composition Codeine was banned.


    Presently, in effect, certain companies will be restricted to retain the brand name in medicines that have undergone alteration in raw material (active pharmaceutical ingredient). It could not be ascertained whether this would apply with retrospective effect, reports the daily.


    The Government is of the strong opinion that carrying a brand name in a new or changed formulation wherein the ingredients of the same have been modified is misleading and detrimental for the patients.


    On the other hand, companies continue to argue since they have invested in building a brand and it enjoys loyalty, they should be permitted to benefit from its value, report TOI.


    The issue has been deliberated for a decade now in several Drugs Consultative Committee meetings.


    Also Read: Glenmark launches SGLT2 Inhibitor Remogliflozin under brand names Remo, Remozen

    active ingredientAPIbanbrandbrand namebrand namesbranded drugschaned formulationchanged formulationcodeineCombination drugCorexCorex DZdrug brandsdrug compositiondrug controlleregovernmentMACBERYMacbery syrupMedical literatureold APIPanderm NMPanderm PlusPfizerpopular brand namestate drug regulatortrade nametweaked formulationZedexZedex plusZEETZeet syrupZifi AZZifi OZ
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok